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Abstract
Ketamine, a mild hallucinogenic class C drug, is the fastest growing ‘party drug’ used by 16–24 year olds in the UK. As the
recreational use of Ketamine increases we are beginning to see the signs of major renal and bladder complications. To date
however, we know nothing of a role for Ketamine in modulating both structure and function of the human renal proximal
tubule. In the current study we have used an established model cell line for human epithelial cells of the proximal tubule
(HK2) to demonstrate that Ketamine evokes early changes in expression of proteins central to the adherens junction
complex. Furthermore we use AFM single-cell force spectroscopy to assess if these changes functionally uncouple cells of
the proximal tubule ahead of any overt loss in epithelial cell function. Our data suggests that Ketamine (24–48 hrs)
produces gross changes in cell morphology and cytoskeletal architecture towards a fibrotic phenotype. These physical
changes matched the concentration-dependent (0.1–1 mg/mL) cytotoxic effect of Ketamine and reflect a loss in expression
of the key adherens junction proteins epithelial (E)- and neural (N)-cadherin and b-catenin. Down-regulation of protein
expression does not involve the pro-fibrotic cytokine TGFb, nor is it regulated by the usual increase in expression of Slug or
Snail, the transcriptional regulators for E-cadherin. However, the loss in E-cadherin can be partially rescued
pharmacologically by blocking p38 MAPK using SB203580. These data provide compelling evidence that Ketamine alters
epithelial cell-to-cell adhesion and cell-coupling in the proximal kidney via a non-classical pro-fibrotic mechanism and the
data provides the first indication that this illicit substance can have major implications on renal function. Understanding
Ketamine-induced renal pathology may identify targets for future therapeutic intervention.
Citation: Hills CE, Jin T, Siamantouras E, Liu IK-K, Jefferson KP, et al. (2013) ’Special K’ and a Loss of Cell-To-Cell Adhesion in Proximal Tubule-Derived Epithelial
Cells: Modulation of the Adherens Junction Complex by Ketamine. PLoS ONE 8(8): e71819. doi:10.1371/journal.pone.0071819
Editor: Steen Henning Hansen, Children’s Hospital Boston, United States of America
Received April 4, 2013; Accepted July 3, 2013; Published August 29, 2013
Copyright:  2013 Hills et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the generous support of The Teresa Rosenbaum Golden Charitable Trust (Rosetree Trust). AFM-SCFS was made possible by
the support of an equipment grant from Diabetes UK (BDA: 12/0004546). The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: C.Hills@warwick.ac.uk
Introduction
Ketamine is a tranquilliser that has also found use as an NMDA
receptor antagonist in the treatment of human bipolar disorders
[1]. However, in 2006 the UK government made Ketamine a class
C drug. Possessing mild hallucinogenic properties, Ketamine is
rapidly replacing heroin and methamphetamine as the recrea-
tional drug of choice [2]. Cheap to buy and easily accessible,
Ketamine has several street names including ‘‘Special K’’,
‘‘vitamin K’’ and ‘‘LA Coke’’. In 2008, the British Crime Survey
revealed that Ketamine was the fastest growing ‘‘party drug’’
among 16–24 year olds and it has since been dubbed the ‘‘new
ecstasy’’ [3]. In the UK, Ketamine boasts an estimated 125,000
users, with more young people using Ketamine in England and
Wales than heroin and crack cocaine combined. As the number of
users rise, serious side effects are beginning to emerge. First
documented in 2007, Ketamine has been shown to injure the
bladder, causing ulcers (wounds) and fibrosis (stiffening of the
bladder walls and shrinkage) [4]. Patients present with multiple
symptoms including incontinence, bleeding, overactive bladder
and bladder shrinkage, as well as damage to both the kidneys and
the ureter [5]. Despite the growing presentation of these
complications, there is an acute lack of understanding for the
mechanisms that underlie the pathophysiological of Ketamine,
and we urgently need to investigate how this mild hallucinogenic
drug scars bladder and renal tissue to impair function [6].
In adults, wound repair is commonly associated with the
accumulation of scar tissue (fibrosis or sclerosis). Its effects are
variable and often impaired by disease or other pathophysiological
insult (e.g. diabetes/drug abuse) [7]. Fibrosis involves excess
accumulation of extracellular matrix (ECM), primarily composed
of collagen. As normal tissue is replaced with scar tissue, a number
of phenotypic and morphological changes occur and the fibrosis
ultimately results in loss of function [8]. Regardless of etiology,
patients subsequently exhibit a progressive decline in organ
function, a largely irreversible process that, in the case of
Ketamine abuse, can lead to removal of the bladder and potential
end stage renal disease. In both the bladder and kidney, early
changes in protein expression/function often occur before overt
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fibrosis. These changes include a loss of epithelial integrity and
dysregulated formation of the intercellular junction, involving, loss
of epithelial E-cadherin, altered cell morphology, re-organisation
of the cytoskeleton and de-novo expression of fibroblastic markers
[9]. Cadherins have a central role in the formation of the multi-
protein adherens junction, which links cell-cell contact to the actin
cytoskeleton and various other signalling molecules [10]. The
extracellular domain of the cell adhesion protein E-cadherin
mediates ligation with neighbouring cadherins on adjacent cells
[11], whilst the cytoplasmic domain binds to b-catenin linking
cadherin to the actin cytoskeleton via a-catenin. The functional
interaction of cadherin with F-actin, via the catenins, not only
serves to increase adhesive strength of the junction but also acts as
a signalling ‘node’ for proteins that influence adhesiveness &/or
initiate intracellular signalling. The loss of E-cadherin mediated
cell-to-cell adhesion represents a pivotal step in the transition of
renal tubule cells from an epithelial phenotype to one more
commonly associated with fibrosis [12]. Down-regulation of E-
cadherin precedes changes in cell morphology, reorganisation of
cell architecture and the subsequent gain in expression of
phenotypic markers associated with renal pathology [12–13].
In the renal tubule, epithelial function depends on complex cell-
cell interactions mediated through the adherens junction. In the
current study we present data outlining early toxicological effects
of Ketamine on proteins critical to formation of the adherens
junction complex in the kidney. Using pharmacological manipu-
lation, we examine potential cellular mechanisms orchestrating
these changes and utilise high resolution AFM-single-cell force
spectroscopy to assess the functional consequence of cell-cell
tethering in Ketamine-treated cells exhibiting a loss in cadherin
expression. Our data provide compelling evidence that Ketamine
reduces cell-cell adhesion in epithelial cells of the proximal tubule.
Translated to the in vivo scenario, the subsequent loss of epithelial
integrity, structure and function may in part contribute to the
toxicological and potential fibrotic response to Ketamine in the
kidney.
Methods
Supplies for tissue culture were purchased from Invitrogen
(Paisley, UK). Immobilon P membrane was from Millipore,
Watford, UK and ECL from Amersham Biosciences, Buckin-
ghamshire, UK. A Qproteome kit was obtained from Qiagen
(Sussex, UK). Antibodies were obtained from Santa Cruz (CA,
USA) and R&D systems (Abingdon, UK). Ketamine, TRITC-
Phalloidin and Fibronectin, were obtained from Sigma (Poole,
UK), as were all other general chemicals. Anti-TGF-b1 ELISA
was obtained from R&D systems.
Model Cell Line
HK2 cells were obtained from the ATCC Bio-resource Centre
(LGC Standards. Middlesex, UK). Cells (passages 18–30) were
maintained in DMEM/Hams F12 (DMEM/F12) medium,
supplemented with 10% fetal calf serum (FCS), glutamine
(2 mM), and EGF (5 ng/ml) and cultured at 37uC in a humidified
atmosphere of 5% CO2. Prior to treatment, cells were transferred
to DMEM/F12 low glucose (5 mM) for 48 hr as described
previously [14]. Cells were serum starved overnight before
applying either Ketamine (0–1 mg/mL) in the presence/absence
of signalling inhibitors Wortmannin (2 mM), PD98059 (10 mM),
and SB203580 (1 mM) for 24 hr. Cells were pre-incubated for
30 minutes with their corresponding inhibitors prior to Ketamine
application. For assessment of Smad activity HK2 cells were
incubated for 0–10 minutes with Ketamine (1 mg/mL).
MTT Assay
The 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) assay is widely used for cytotoxicity assessments of
pharmacological and chemical agents. Viable cells transport MTT
into their mitochondria, the compound is then reduced to
formazin (purple in color), and the latter is quantified color-
ometrically. The amount of color formed corresponds to the
number of viable cells. HK2 cells were cultured in 96-well plates
(56103 cells/well) in 5 mM glucose containing media for 48 hrs
prior to an overnight period of serum starvation. Cells were
stimulated for 24 and 48 hrs with Ketamine (0.1–1 mg) and
proliferation analyzed using the MTT colorimetric assay (Roche)
according to manufacturers instructions. The values were
presented as a percentage of the MTT uptake that was observed
as compared to control cells.
Lactate Dehydrogenase Assay
Cell death or cytotoxicity is classically evaluated by the
quantification of plasma membrane damage. Lactate dehydroge-
nase (LDH) is a stable enzyme, present in all cell types, and rapidly
released into the cell culture medium upon damage of the plasma
membrane. Therefore, LDH is a common marker used to
determine cytotoxicity. HK2 cells were cultured in 96-well plates
(56103 cells/well) in 5 mM glucose containing media for 48 hrs
prior to an overnight period of serum starvation. Cells were
stimulated for 24 and 48 hrs with Ketamine (0.1–1 mg) and
Lactate dehydrogenase levels assayed using the LDH-cytoxicity
assay kit II (Abcam) according to manufacturers instructions. The
values were presented as a percentage of the LDH release that was
observed as compared to control cells.
Crystal Violet Assay
This is a simple assay useful for obtaining quantitative
information about the relative density of cells adhering to multi-
well cluster dishes. Crystal Violet stains DNA and upon
solubilization, the amount of dye taken up by the monolayer can
be quantitated in a plate reader. HK2 cells were cultured in 96-
well plates (56103 cells/well) in 5 mM glucose containing media
for 48 hrs prior to an overnight period of serum starvation. Cells
were stimulated for 24 and 48 hrs with Ketamine (0.1–1 mg) and
cell density determined with crystal violet staining. Briefly, media
was removed and cells were fixed for 10 mins with PFA. Following
a brief wash with PBS, cells were incubated for 10 mins at room
temperature in a 1% Crystal Violet solution. After this time
interval, all traces of dye were removed with distilled water and the
stain solubilized with 1% SDS. The values were presented as a
percentage of cells staining in Ketamine treated cells as compared
to control cells.
Quantification of TGF-b1
HK2 cells were cultured in 5 mM glucose containing media for
48 hrs prior to an overnight period of serum starvation. Cells were
stimulated for 24 hrs with Ketamine (0.1–1 mg) under serum-free
conditions and total TGF-b1 was measured by specific enzyme-
linked immunosorbent assay (ELISA) of cell culture supernatant
collected from growth-arrested HK2 cells. Active TGF-b1 is
measured directly and latent TGF-b1 can be measured indirectly
following acid activation of samples. This assay has ,1% cross-
reactivity for TGF-b2 and TGF-b3. TGF-b1 concentration was
normalized to mg/ml of protein. Data were obtained as picograms
of TGF-b1 per milliliter per mg of protein and are expressed as a
percent as compared to control.
Ketamine and the Adherens Junction
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Figure 1. Impact of Ketamine on HK2 cell viability, as assessed by phase contrast microscopy, MTT uptake, Crystal Violet staining
and LDH release. HK2 cells were cultured in 5 mM glucose containing media for 48 hrs prior to an overnight serum starvation. Cells were
stimulated for 24–48 hrs with Ketamine (0.1–1 mg/mL) under serum-free conditions and morphological changes assessed (Panels A and B
respectively). Ketamine evoked a concentration dependent change in cell morphology from a typical proximal tubular epithelial ‘‘cobblestone’’
appearance to an elongated fibroblast appearance. Cell viability was assessed by MTT uptake at 24 and 48 hrs (panels C and D respectively).
Incubation with Ketamine at 0.5 and 1 mg/mL caused a significant decrease in viable cells as measured by MTT uptake. Cell membrane damage was
assessed via LDH release at 24 and 48 hrs (panels E and F respectively). At both 24 and 48 hrs, Ketamine (1 mg/mL) caused a significant increase in
LDH release. Finally cell density was determined by the Crystal violet assay. Ketamine evoked a reduction in cell density at 24 and 48 hrs (panels G
and H respectively). The values obtained are expressed as a % of control (C). Results are representative of 3 separate experiments. Key significances
are shown where **P,0.01 and ***P,0.001.
doi:10.1371/journal.pone.0071819.g001
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Immunoblotting
Cytosolic proteins were prepared and separated by gel
electrophoresis and electro-blotting onto Immobilon P membranes
as described previously [15]. For determination of protein
localization, proteins were harvested using the Qproteome cell
compartment kit. Membranes were probed with specific polyclon-
al antibodies against anti-E-cadherin (1:2000), N-Cadherin
(1:1000), Snail (1:1000), Slug (1:1000), (1:2000), p-Smad 2
(1:1000), p-Smad 3(1:1000) (all R&D systems) and beta-catenin
(1:1000) (Santa Cruz).
Immunocytochemistry
Cells at 80% confluence were fixed with 4% paraformaldehyde
(PFA). Following blocking, the nuclear stain 49, 6-diamidino-2-
phenylindole, dihydrochloride (DAPI; 1 mM) was added for
3 mins. Cells were then incubated with TRITC-conjugated
phalloidin (Sigma) diluted at 1:100 in PBS-Triton for 1 hr at
25uC. Fluorescence was visualized using an Axiovert 200
fluorescence microscope (Carl Zeiss, Welwyn Garden City, UK).
Single Cell Force Spectroscopy
Atomic Force Microscopy (AFM) Single-Cell Force Spectros-
copy (CellHesionH module, JKP Instruments Germany) was used
to measure cell-cell adhesion and the separation forces required to
uncouple cells cultured in Ketamine as compared to control
untreated cells. A single HK2 cell was bound to a cantilever using
fibronectin (20 mg/ml) and poly-l-lysine (25 mg/ml) and subse-
quently brought into contact with an adherent cell (in a cluster of
coupled cells) using a known force (1 nN). The two cells remained
in contact for a defined period of time (10 sec) whilst bonding
formed. The cantilever was then retracted at a constant speed
(5 mm/sec) and force (nN) versus displacement (deflection of the
cantilever) measured by the position of a laser beam reflected from
the cantilever, until the cells were completely separated (pulling
length 90 mm). Each cell-cell recording was repeated in triplicate
with a 30 sec pause interval between successive measurements.
Retraction recordings from multiple cells (approx. 40) in separate
experiments (n = 4) were made and the maximum unbinding force
(nN) and the detachment energy (fJoules) calculated.
Analysis
Autoradiographs were quantified by densitometry using Total-
Lab 2003 (NonLinear Dynamics, Durham, NC USA). Where data
was quantified, the non-stimulated, low glucose control condition
was normalized to 100% and data from all other experimental
conditions compared to this. Statistical analysis of data was
performed using a one-way ANOVA test with a Tukey’s multiple
comparison post-test. AFM data was analysed via t-test. Data are
expressed as mean 6 SEM, where ‘n’ denotes the number of
experiments. A probability (P),0.05 was taken to signify statistical
significance.
Results
The Effect of Ketamine on Cell Viability and Cytoxicity
Cells were cultured in 5 mM glucose for 48 hrs prior to being
serum starved overnight. Cells were either unstimulated (control)
or stimulated for 24–48 hrs with Ketamine (0.1–1 mg/mL) under
serum-free conditions. Phase contrast microscopy revealed that
control HK2-cells exhibited a typical cobblestone morphology,
characteristic of proximal tubular epithelial cells (Fig. 1, A and B).
Exposure to increasing concentrations of Ketamine (0.1, 0.5 and
1 mg/mL) for 24 or 48 hrs evoked a concentration-dependent
change in morphology towards an elongated fibrous phenotype.
Furthermore, cells treated for 48 hrs at the highest concentration
(1 mg/mL), appeared to exhibit cytosolic granulation and a
reduction in cell number (Fig. 1B).
Cells stimulated for 24 and 48 hrs with Ketamine (0.1–1 mg/
mL) under serum-free conditions were assessed for cell viability by
MTT uptake (uptake directly correlates with the number of viable
cells). At 24 hrs, incubation with Ketamine at 0.5 and 1 mg/mL
significantly decreased viability by 2264% and 3965% respec-
tively as compared to control (Fig. 1C, P,0.001, n= 3). At 48 hrs,
Ketamine decreased cell viability by 2264% (P,0.01), 4163%
(P,0.001) and 4563% (P,0.001) as compared to control over the
same range of concentrations (Fig. 1D, n= 3).
As a complimentary strategy to assess cytotoxicity, we used the
Lactate Dehyrdogenase assay as a marker of LDH release into cell
supernatant of control versus Ketamine-treated cells. To assess
membrane damage, cells were stimulated for 24 and 48 hrs with
Ketamine (0.1–1 mg/mL) under serum-free conditions prior to
measuring LDH release. Results are expressed as a % of LDH
release as compared to control cells. At 24 hrs, Ketamine (1 mg/
mL) increased LDH levels by 62% to 162617% of that under
control (100%) conditions (Fig. 1E, P,0.001, n= 3), At 48 hrs
Ketamine (1 mg/mL) significantly increased LDH levels by 140%
to 240618% as compared to control (Fig. 1F; P,0.001, n= 3).
Release of LDH into the media suggests cell membrane damage
and a concentration-dependent cytotoxic effect of Ketamine.
To further confirm the toxic role of Ketamine, we measured the
number of adherent cells using a crystal violet assay. Cells were
fixed and stained with crystal violet (1% w/v) at 24 and 48 hrs.
Quantification of dye uptake was significantly reduced by 1462%
(P,0.001) and 2961% (P,0.001) at 0.5 and 1 mg/mL respec-
tively as compared to control at 24 hrs (Fig. 1G), and by 2061%
(P,0.001) and 4362% (P,0.001) at 48 hrs over the same range
of concentrations (Fig. 1H, n= 3). Based on our observations from
all three strategies, subsequent analysis determined the effects of
Ketamine (0.1–1 mg/mL) on cell-to-cell adhesion and adherens
junction proteins over the more acute 24 hr time window.
The Effect of Ketamine on Expression of Adherens
Junction Proteins
The transition of tubular epithelial cells from a typical,
cobblestone morphology to a fibrotic phenotype is commonly
associated with reorganisation of cell architecture and alterations
in the expression of epithelial proteins involved in adherens and
tight junction formation [12–13]. HK2 cells were cultured in
5 mM glucose containing media for 48 hrs prior to overnight
serum starvation. Cells were stimulated for 24 hrs with Ketamine
(0.1–1 mg/mL) under serum-free conditions and morphological
and phenotypic changes assessed. At 24 hrs, Ketamine induced a
concentration-dependent change in cell morphology towards an
elongated fibroblast-like phenotype (Fig. 2A). These gross mor-
phological changes were accompanied by re-organisation of the
actin cytoskeleton from a diffuse transcellular network of F-actin
filaments that spanned the cytosol, into more dense peripheral
stress fibres (Fig. 2B).
This architectural reorganisation intimates that Ketamine
causes dysregulation of the adherens junction complex and has
repercussions for the integrity of the epithelial sheet. To resolve
these changes, we examined the effects of Ketamine on adherens
junction proteins and their transcriptional regulators. Ketamine
induced a concentration-dependent decrease in whole-cell expres-
sion of E-cadherin by 2861% (P,0.01), 52612% (P,0.001) and
7663% (P,0.001) as compared to control at 0.1, 0.5 and 1 mg/
mL respectively (n = 3, Fig. 2C). The loss in expression reflected a
loss in E-cadherin from all cell compartments examined (Fig. 2Hi).
Ketamine and the Adherens Junction
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Previously implicated in the differentiation of epithelial cells into
fibroblast, e.g. mesenchymal cells (epithelial-mesenchymal transi-
tions), following down regulation of expression of the adhesion
protein E-cadherin [16–18] we next examined the effect of
Ketamine on whole cell and cell-compartment expression of the
transcriptional repressors Snail (Fig. 2F) and Slug (Fig. 2G). Data
suggests that Ketamine down-regulated whole cell expression of
Snail by 36613% (P,0.05), 5166% (P,0.01) and 6164%
Figure 2. Ketamine evoked changes in AJ-protein expression in HK2-cells. To assess the effect of Ketamine on expression of key AJ
proteins, HK2 cells were cultured in 5 mM glucose containing media for 48 hrs prior to overnight serum starvation. Cells were stimulated for 24 hrs
with Ketamine (0.1–1 mg/mL) under serum-free conditions and morphological and phenotypic changes assessed. Phase contrast microscopy (panel
A) and TRITC conjugated phalloidin (panel B) confirmed the dose dependent effects of Ketamine on cell morphology and cytoskeletal reorganization
respectively. Whole cell expression of E-cadherin and its transcriptional co-repressor Snail were determined by western blotting. Ketamine decreased
expression of E-cadherin (panel C) Snail (panel F) and Slug (panel G). Compartmental localisation of E-cadherin, Snail and Slug expression were
determined for membrane (M), cytosol (C), nuclear (N) and cytoskeletal (CK) fractions +/2 Ketamine (1 mg/mL). Ketamine altered the cellular
localization of all three proteins, compared to control (panels Hi, Hiv and Hv respectively). Ketamine also down-regulated expression of N-cadherin
(panel D) and b-catenin (panel E), with a loss in expression being apparent throughout the cell (panel Hii and Hiii respectively). Upper panels show
representative blots for each protein and re-probed for a-tubulin as a loading control. Lower panels show mean (6SEM) densitometry data,
normalised against the non-stimulated low glucose control (100%), from 3 or more separate experiments. Each lane in the representative blot
corresponds to the associated bar in the graph. Key significances are shown, *P,0.05, *P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0071819.g002
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(P,0.01) as compared to control (100%) and of Slug by 4167%
(P,0.01), 5366% (P,0.01) and 8464% (P,0.001) of control at
0.1, 0.5 and 1 mg/mL respectively (n = 3). Cell compartment
analysis highlighted a predominant loss in expression of both these
transcription factors from the nucleus (Fig. 2Hiv and Fig. 2Hv,
Snail and Slug respectively). Normally exhibiting a reciprocal
relationship’s with E-cadherin these data suggest a toxic, but non-
lethal effect of Ketamine in cells of the proximal tubule.
The cytoplasmic domain of E-cadherin binds to b-catenin to
link cell-adhesion to the actin cytoskeleton Ketamine reduced
whole cell expression of b-catenin by 2866%, 2867% (P,0.05)
and 3962% (P,0.01) as compared to control at 0.1, 0.5 and
1 mg/mL (n= 3, Fig. 2E), an effect attributable to a loss in
expression from all 4 cell compartments (Fig. 2Hiii). In the kidney,
a loss in E-cadherin expression is often paralleled by a concomitant
gain in the expression of neural (N)-cadherin, a mechanism
commonly referred to as the cadherin switch [18–19]. However, in
the current study, Ketamine was unable to induce this compen-
satory switch and Ketamine induced a concentration-dependent
down-regulation in N-cadherin expression. N-cadherin expression
levels decreased in response to Ketamine by to 3167%, 4763%
(P,0.001) and 7562% (P,0.001) as compared to control at 0.1,
0.5 and 1 mg/mL (n= 3, see Fig. 2D). Cell compartment analysis
revealed that the loss in expression of N-cadherin was attributable
to loss in expression at the membrane, nucleus and cytoskeleton
fractions of the cell (Fig. 2Hii).
The Effects of Ketamine are TGF-b1 Independent
It is well established that TGF-b1 is a principal mediator of
fibrotic changes in the kidney. TGF-b1 modulates the expression
of several epithelial cell recognition and organizational proteins,
whilst contributing to the reciprocal loss of tubular epithelial cells
and accumulation of interstitial fibroblasts, changes associated
with declining excretory function [20–21]. To determine if
Ketamine mediated its effects through downstream TGF-b1, we
examined whether Ketamine stimulated TGF-b1 secretion
(Fig. 3A) &/or regulate expression of its downstream signalling
intermediates Smad2 and Smad3 (Fig. 3B and C) [22]. Cells were
cultured in 5 mM glucose containing media for 48 hrs prior to an
overnight serum starvation. Cells were stimulated for 24 hrs with
Ketamine (0.1–1 mg/mL) under serum-free conditions and
ELISA was used to measured total TGF-b1 secretion from
growth-arrested HK2 cells. Ketamine significantly decreased total
TGF-b1 secretion from basal control conditions (20 pg/ml) by
69611% at 0.5 and 8366% at 1 mg/mL as compared to control
(P,0.01; Fig. 3A). Differences in TGF-b1 were only detected
following acidification of the samples, suggesting that TGF-b1 was
produced in its latent form (data not shown). Smad activity was
assessed via immunoblotting. HK2 cells were cultured in 5 mM
glucose containing media for 48 hrs prior to overnight serum
starvation. Cells were stimulated for 0–30 minutes with Ketamine
(1 mg/mL) and expression levels of p-Smad2 and p-Smad3
examined. P-Smad2 expression levels decreased by 663%,
12617%, 3767%, and 6864% (P,0.01), at 1, 5, 10 and 30
minutes respectively as compared to control (Fig. 3B, n = 3). P-
Smad3 expression levels were also altered in response to Ketamine
with levels decreasing 2466%, 3767% (P,0.01), and 7965%
(P,0.001), at 5, 10, and 30 minutes respectively as compared to
control (Fig. 3C, n = 3). The decrease in TGF-b1 secretion with a
concomitant reduction in the associated signalling intermediaries,
i.e. Smad 2 and 3, and the inability of Ketamine to induce
reciprocal up-regulation of Snail and N-cadherin to coincide with
a loss in E-cadherin, suggest that the cytotoxic effects of Ketamine
are independent of TGF-b1.
Figure 3. Ketamine inhibits TGF-b1 secretion and down-
regulates P-Smad2 and P-Smad3 expression in HK2 cells. HK2
cells were cultured in 5 mM glucose containing media for 48 hrs prior
to overnight serum starvation. Cells were stimulated for 24 hrs with
Ketamine (0.1–1 mg/mL) under serum-free conditions. The supernatant
was removed and TGF-b1 secretion quantified by ELISA and expressed
as % TGF-b1 secretion as compared to control (panel A). Results are
representative of 3 separate experiments. Key significances are shown
Ketamine and the Adherens Junction
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Ketamine Stimulates Downstream MAPK Signalling in
HK2 Cells
HK2 cells were cultured in 5 mM glucose containing media for
48 hrs prior to overnight serum starvation. Cells were stimulated
for 0–30 minutes with Ketamine (1 mg/mL) and expression levels
of p-P38 and p-P42/44 assessed by immunoblotting (Fig. 4). P-
ERK expression levels increased by 166611% (P,0.01),
222627% (P,0.01) and 259630% (P,0.01), at 1, 5 and 10
minutes respectively as compared to control (Fig. 4A, n= 3). p-P38
expression levels were also altered in response to Ketamine with
levels increasing by 6364% (P,0.01), and 98625% (P,0.001), at
10 and 30 minutes respectively as compared to control (Fig. 4B,
n = 3).
Signalling Cascades Regulating the Effects of Ketamine
on the Adherens Junction Complex
Having confirmed that Ketamine does not depend on TGF-b
dependent signalling and that it can evoke activation of MAPK
signalling, we examined whether the morphological and pheno-
typic effects of Ketamine could be arrested or reversed by
pharmacological intervention with downstream inhibitors of the
MAPK pathway. Cells were cultured in 5 mM glucose containing
media for 48 hrs prior to an overnight serum starvation. Cells
were stimulated for 24 hrs with the highest, non-lethal concen-
tration of Ketamine (1 mg/mL) in the presence or absence of
wortmannin (2 mM), PD98059 (10 mM), and SB203580 (1 mM)
under serum-free conditions. Phase contrast morphology con-
firmed that incubation with wortmannin, PD98059, or SB203580
partly reversed gross Ketamine induced changes in cell morphol-
ogy (See Fig. 5A). Qualitatively, SB203580 treated cells most
closely resembled the cobblestone appearance observed under
control conditions, and suggest that p38 MAPK may partially
mediate the Ketamine response. Restoration of a normal cellular
architecture may reflect the partial reclamation of E-cadherin
expression following SB203580 treatment (see Fig. 5C). Contra-
dictory to this, TRITC-conjugated phalloidin, suggested that the
pattern of filamentous F-actin staining seen in control cells, was
partially restored following treatment with the ERK inhibitor
PD98059 and not SB203580 (Fig. 5B).
In order to assess changes in protein expression following
inhibition of candidate signaling pathways, cells were cultured in
5 mM glucose for 48 hrs prior to an overnight serum starvation.
Cells were then stimulated for 24 hrs with Ketamine in the
presence or absence of wortmannin (2 mM), PD98059 (10 mM),
and SB203580 (1 mM) under serum-free conditions. Whole cell
expression of candidate proteins was assessed. At 24 hrs,
Ketamine (1 mg/mL) decreased E-cadherin expression by
4867% of control (Fig. 5C P,0.001). This effect was compound-
ed by co-incubation with the PI3-K inhibitor wortmannin, with
expression decreasing a further 36% giving a 7465% reduction in
E-cadherin expression as compared to control. Whilst wortmannin
exacerbated the effect of Ketamine, PD98059 failed to signifi-
cantly alter the Ketamine-evoked loss in E-cadherin. Blocking p38
MAPK improved cadherin expression in response to Ketamine
(n= 3; P,0.01), increasing expression by 15% to 6362% of that
under control conditions and suggesting a role for p38 MAPK in
regulating the effects of Ketamine on E-cadherin mediated cell
adhesion (Fig. 5C).
Contrary to the data above, wortmanin completely reversed the
inhibitory effects of Ketamine on Snail expression (P,0.01) and
actually increased expression levels by 11% as compared to that
observed under control control conditions (111614%, n= 3)
(Fig. 5F). As a negative regulator of E-cadherin, an increase in
Snail in response inhibition of PI3-K could account for the
exacerbated reduction of E-cadherin expression observed in
Fig. 5C. The transcriptional repressors Snail and Slug are both
situated at the core of several signaling pathways proposed to
mediate EMT and are central to the regulation of E-cadherin [12–
where **P,0.01 and ***P,0.001. Whole cell expression of p-Smad2
(panel B) and p-Smad3 (panel C) were determined by immuno-blotting.
HK2 cells were cultured in 5 mM glucose containing media for 48 hrs
prior to overnight serum starvation. Cells were stimulated for 0–
30 minutes with Ketamine (1 mg/mL) under serum-free conditions.
Upper panels show representative blots for each protein and re-probed
for Total Smad as a loading control. Lower panels show mean (6SEM)
densitometry data, normalised against the non-stimulated low glucose
control (100%), from 3 or more separate experiments. Each lane in the
representative blot corresponds to the associated bar in the graph. Key
significances are shown, **P,0.01, *** P,0.001.
doi:10.1371/journal.pone.0071819.g003
Figure 4. Ketamine stimulates phosphorylation of ERK and p38 MAPK. HK2 cells were cultured in 5 mM glucose containing media for 48 hrs
prior to overnight serum starvation. Cells were stimulated with Ketamine (1 mg/mL) for 0–30 minutes under serum free conditions and expression of
p-ERK and p-P38 assessed by immunoblotting. Upper panels show representative blots for each protein and re-probed for Total ERK and Total p38
respectively as a loading control. Lower panels show mean (6SEM) densitometry data, normalised against the non-stimulated low glucose control
(100%), from 3 or more separate experiments. Each lane in the representative blot corresponds to the associated bar in the graph. Key significances
are shown, **P,0.01, *** P,0.001.
doi:10.1371/journal.pone.0071819.g004
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Figure 5. The role of PI3-K, ERK and p38 MAPK in mediating the Ketamine response. HK2 cells were cultured in 5 mM glucose containing
media for 48 hrs prior to overnight serum starvation. Cells were stimulated with Ketamine (1 mg/mL) for 24 hrs in the presence or absence of
Wortmannin (2 mM), PD98059 (10 mM), and SB203580 (1 mM) under serum-free conditions. Phase contrast microscopy (panel A) and TRITC
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13]. As with Snail, Ketamine decreased Slug expression (Fig. 5G)
by 7264% as compared to control (P,0.001). Neither wortman-
nin nor SB203580 were able to significantly attenuate the
inhibitory effect of Ketamine, however, inhibition of ERK
regained the expression of Slug (P,0.05), and suggests potential
involvement of ERK in regulating the effects of Ketamine over
Slug expression (n= 3). In support of the data in Fig. 2, Ketamine
evoked a down-regulation in both N-cadherin and b-catenin with
expression levels decreasing by 7363% and 5064% respectively
as compared to control (P,0.001; Fig. 5D and E). None of the
inhibitors were able to negate the effects of Ketamine on these two
proteins. It should be noted that treatment with inhibitors alone,
did not significantly alter the expression of our five candidate
proteins (see Figure S1).
Ketamine Reduces Functional Tethering between Cells of
the Proximal Tubule
Atomic Force Microscopy (AFM) Single-Cell Force Spectros-
copy was used to measure cell-to-cell adhesion and the separation
forces and energies required to uncouple cells [23]. Prior to
attachment, cells were cultured for 48 hrs under identical
conditions +/2 Ketamine (0.1–1 mg/mL). A single HK2 cell
was bound to a cantilever and subsequently brought into contact
with an adherent cell within a cluster, using a fixed force. After
10 sec, the cantilever was retracted (5 mm/sec) and force versus
displacement measured until the cells were completely separated.
Retraction force-displacement curves provide important informa-
tion regarding the adhesion between two cells, such as the energy
required to separate them (the grey area in Fig. 6A–D) and
maximum force of detachment (the red circles in Fig. 6A–D). The
energy required to separate two cells is normally referred to as
‘‘detachment energy’’ (Fig. 6E) whilst the maximum force of
detachment for complete separation the ‘‘maximum unbinding
force’’ (Fig. 6F). The retraction measurements of control versus
Ketamine (0.1–1 mg/mL)-treated cells are shown in panels E & F.
In each case, data is recorded from multiple cells (.10) in 4
separate experiments at each concentration. Compared to control
(0 mg/mL), Ketamine evokes a concentration-dependent decrease
in the maximum unbinding force by 3366%, 4163%, and
5866% at 0.1 mg/mL, 0.5 mg/mL and 1 mg/mL respectively
(P,0.001), whilst the detachment energy decreased by 3268%,
6367%, and 86611% of control at 0.1 mg/mL, 0.5 mg/mL and
1 mg/mL respectively (P,0.001).
Discussion
In the UK, Ketamine is fast becoming the ‘‘party drug’’ of
choice amongst 16–24 year olds. The Independent Scientific
Committee on Drugs (ISCD) found that 68% of UK clubbers had
taken the drug in 2009, whilst the British Crime Survey reported
an increase in users from 85,000 in 2006/07 to 113,000 in 2008/
09 [2]. Although effective as a mild hallucinogen at 60 mg to
100 mg, some users are reportedly taking 5 g to 10 g a day.
Stimulated by public concern about the popularity and potential
harms of Ketamine, our study coincides with a recent BBC report
in which the UK Home Secretary Theresa May, asked the
Advisory Council on the Misuse of Drugs (ACMD) to update their
advice on the abuse of ketamine. As the number of users increases,
serious side effects are beginning to emerge. These effects,
including bladder shrinkage, fibrosis, incontinence and bleeding,
can ultimately lead to complete destruction and subsequent
removal of the bladder [4]. Whilst the effects of Ketamine on
the bladder are established, recent evidence suggests that damage
to other tissues is also on the increase, and patients regularly
present with both bladder and renal complications [24]. The
escalating problem highlights an urgent need to improve our
understanding of how Ketamine mediates its effects on the entire
urological system.
In epithelia cells of the proximal tubule, disease-induced fibrosis
commonly presents with cell atrophy, increased matrix deposition
and tubulointerstitial scarring, all of which culminate in a loss of
renal function [25–27]. The reciprocal loss of tubular epithelial
cells and accumulation of interstitial fibroblasts promotes chronic
fibrosis. Characteristic changes include morphological and phe-
notypic alterations with cytoskeletal reorganization and the down-
regulation of epithelial cell adhesion molecules, such as E-
cadherin. The integrity of the adherens junction is vital to
maintain basic epithelial function and the loss of E-cadherin
mediated cell-adhesion represents a pivotal step in early pheno-
typic and morphological changes observed in tubular injury [25]
[28].
Changes in adherens junction proteins are central to early
morphological and phenotypic alterations that precede overt signs
of tissue damage. The aim of the current study was to understand
of how Ketamine altered cell adhesion and cell-coupling in
epithelial cells of the proximal tubule. Assessing cell morphology
confirmed that Ketamine produced a concentration-dependent
change in cellular architecture towards an elongated fibrotic
phenotype at 24 and 48 hrs. The reduction in both MTT uptake
and crystal violet staining was consistent with reduced cell viability
and concomitant to an increase of lactate dehydrogenase release,
confirming cytotoxicity. We confirmed that Ketamine reduced
membrane expression of E-cadherin and showed for the first time
that the drug decreases functional tethering between cells of the
proximal tubule, a potentially catastrophic event in cells whose
primary function depends on formation of a tight epithelial sheet.
Whilst our previous studies in the proximal tubule suggest that a
pro-fibrotic loss of E-cadherin is paralleled by an up-regulation of
transcriptional repressors Snail and Slug, the effects of Ketamine
appear toxic and are not mediated via classic signalling pathways
[17–18].
The actin cytoskeleton stabilizes both tight junctions and
adherent junctions and alterations in actin dynamics disrupt E-
cadherin-mediated adhesion [29–30]. TRITC-conjugated phal-
loidin revealed that Ketamine redistributed F-actin in to stress
fibres at the cell periphery. This data was supported by a
significant reduction in expression of E-cadherin at the cell
membrane, a response that, unlike classic renal fibrosis, was not
paralleled by up-regulation in expression of transcription factors
Snail and Slug. Furthermore, the cadherin-switch associated with
conjugated phalloidin (panel B) were used to confirm if blockade of PI3-K, ERK or p38 MAPK was able to negate Ketamine-induced changes in cell
morphology and cytoskeletal reorganization. HK2 cells were cultured in 5 mM glucose containing media for 48 hrs prior to overnight serum
starvation. Cells were stimulated with Ketamine (1 mg/mL) for 24 hrs in the presence or absence of Wortmannin (2 mM), PD98059 (10 mM), and
SB203580 (1 mM) under serum-free conditions and the expression levels of E-cadherin (panel C), N-cadherin (panel D), b-catenin (panel E), Snail (panel
F) and Slug (panel G) determined by immuno-blotting. Upper panels show representative blots for each protein and re-probed for a-tubulin as a
loading control. Lower panels show mean (6SEM) densitometry data, normalised against the non-stimulated low glucose control (100%), from 3 or
more separate experiments. Each lane in the representative blot corresponds to the associated bar in the graph. Key significances are shown,
*P,0.05, * P,0.01, *** P,0.001.
doi:10.1371/journal.pone.0071819.g005
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EMT [18–19] and favouring the up-regulation of neural (N)-
cadherin to replace the loss in E-cadherin, did not occur. These
data suggest that the effects of Ketamine are cytotoxic, and not
mediated through classic, canonical pathways usually associated
with renal fibrosis.
TGF- b1 is a pro-fibrotic cytokine known to play an important
role in the pathogenesis of disease-induced renal fibrosis, e.g.
diabetic nephropathy [27]. Having previously shown that TGF-
b1 instigates a loss in E-cadherin expression in HK2-cells, we
investigated if Ketamine directly altered TGF- b1 secretion [18].
Ketamine (1 mg/mL) reduced TGF- b1 secretion to 80% of
control. In renal fibrosis, TGF- b1 binds to a trans-membrane
TBRII receptor and initiates several intracellular signalling
cascades, including the small mothers against decapentaplegic
(SMADs) and mitogen activated protein kinases (MAPK), such as
extracellular regulated kinase (ERK), p38 and Jun Kinase [22].
The majority of TGF- b1 targeted genes regulated in fibrosis rely
on Smad3-dependent transcriptional regulation (Brown et al.
2007). In the current study, Ketamine not only decreased TGF-
b1 secretion but also down-regulated p-Smad2 and p-Smad3
expression at 24 hours. The failure of Ketamine to stimulate
canonical TGF- b1 signalling suggests that an alternative
Figure 6. Ketamine reduces cell adhesion. AFM-single-cell force spectroscopy was used to measure the detachment energy (fJoules) and maximum
unbinding force (nN) required to uncouple two HK2 cells. The energy required to separate the cells; grey area in panel A (control cells), panel B
(0.1 mg/mL Ketamine treated cells), panel C (0.5 mg/mL Ketamine treated cells), and panel D (1 mg/mL Ketamine treated cells), and maximum force
of detachment (red circle) was measured. The former is known as the ‘‘detachment energy’’ (panel E) and the later is ‘‘maximum unbinding force’’
(panel F). Ketamine decreased the maximum unbinding force and the work of adhesion in a dose dependent manner compared to control. Data is
expressed as mean 6 SEM. of multiple cells from 4 separate experiments, where key significances are shown, **** P,0.0001.
doi:10.1371/journal.pone.0071819.g006
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mechanism must mediate Ketamine-evoked effects. Co-incubation
of Ketamine with inhibitors of PI3-K, p38 MAPK and ERK
confirmed a partial role for all three in regulating our candidate
proteins. There was a counter-intuitive relationship observed
between E-cadherin and Snail in response to Ketamine treatment
in the presence of the PI3-K inhibitor wortmannin. Blockade of
PI3-K signalling further reduced the expression of E-cadherin, an
effect most likely to reflect the dramatic up-regulation Snail under
the same conditions. This suggests that Ketamine down-regulates
Snail expression in a PI3-K dependent manner and that blockade
of this pathway restores the reciprocal relationship between E-
cadherin and its transcriptional repressor. Inhibition of p38MAPK
partially restored E-cadherin expression to those of control, an
effect that may, in part, be responsible for the restoration of cell
morphology observed with SB203580. Co-incubation of Ketamine
with wortmannin failed to negate the inhibitory effects of
Ketamine on Slug, whilst the ERK inhibitor, PD98059, restored
expression to approximately 50% of control, indicating a
downstream involvement ERK in regulating Slug. Whilst it was
evident that PI3-K and ERK have a role in regulating E-cadherin,
Snail and Slug, elucidating the pathway controlling N-cadherin
and b-catenin expression was not clear. Ketamine reduced the
expression of both these proteins and the effect could not be
restored by pharmacological inhibition.
To determine how a loss in adherens junction proteins
functionally affected cell-cell adhesion, we used AFM-SCFS.
The AFM-single-cell force spectroscopy used in this study has a
displacement actuator of longer travelling distance (up to 100 mm)
which provides an excellent capability for measuring the complete
force-displacement curve of cell detachment and is essential when
studying large cells such as those as found in renal tubule epithelia.
Retraction force-displacement curves allow us to determine the
force and energy required to uncouple cells. The former is
normally referred to as ‘‘adhesion force’’ and the latter the
‘‘detachment energy’’, which can be calculated from the integra-
tion of the separation force-displacement curves, i.e. the grey area
under the curve in Fig. 6A–D. Retraction force-displacement
curves confirmed that 1 mg/mL Ketamine reduced the maximum
unbinding force required to begin separation of two cells by 58%,
whilst reducing the detachment energy required to completely
separate them by 86%. The greater decrease in the detachment
energy could be partly explained due to the increase in cell rigidity
following Ketamine treatment, as demonstrated by re-arrange-
ment of the cytoskeleton into peripheral stress fibres. These data
suggest that it is the loss in E-cadherin expression and dissolution
of the catenin/cadherin complex, which drives the detachment of
cells in response to Ketamine.
In the current study, we report on Ketamine-evoked cytotoxic
damage to epithelial cells of the proximal tubule. The acute effects
of Ketamine are associated with early functional changes in the
adherens junction complex. This loss in expression of proteins
central to cell-adhesion, promotes functional disassociation of the
epithelia, and is the most likely cause of early morphological and
phenotypic alterations observed following Ketamine exposure.
The reported changes may represent the initial basis for overt
renal complications of Ketamine abuse. Whilst our studies provide
novel and exciting data on the effects of this recreational drug in
the proximal tubule, it is clear that this area of research demands
fuller investigation. To reduce the confounding influence of the
multifactorial molecular pathology that is likely to underlie
Ketamine-induced renal damage within epithelia cells of the
proximal tubule, we utilized the well-characterized human HK2
cell line as a minimalistic model. Despite HK2 cells having many
advantages to primary tissue, the authors concede that responses
are open to modification by the complexities of the in vivo
situation. Despite this caveat, the current data provides a
compelling foundation, identifying likely targets associated with
early Ketamine damage, and as such, identifies future candidates
for maintaining or restoring renal function in response to and from
this toxic substance particularly given the catastrophic tissue
damage reported for the bladder. Future work will need to
extrapolate these data in to the primary scenario.
Supporting Information
Figure S1 The effect of Inhibitors alone on candidate
protein expression in HK2 cells. HK2 cells were cultured in
5 mM glucose containing media for 48 hrs prior to overnight
serum starvation. Cells were treated for 24 hrs with Wortmannin
(2 mM), PD98059 (10 mM), and SB203580 (1 mM) under serum-
free conditions and the expression levels of E-cadherin (panel A),
N-cadherin (panel B), b-catenin (panel C), Snail (panel D) and
Slug (panel E) determined by immuno-blotting. Upper panels
show representative blots for each protein and re-probed for a-
tubulin as a loading control. Lower panels show mean (6SEM)
densitometry data, normalised against the non-stimulated low
glucose control (100%), from 3 or more separate experiments.
Each lane in the representative blot corresponds to the associated
bar in the graph.
(TIFF)
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